Detection of myelin autoantibodies: Evaluation of an assay system for diagnosis of multiple sclerosis in differentiation from other central nervous system diseases

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 11, 2009, Pages 1395-1400

  Langkamp, Markus ^a   Hörnig, Stephanie C ^b   Hörnig, Joachim B ^b   Kirschner, Marion ^a   Pridzun, Lutz ^a   Kornhuber, Malte E ^c  

^a Mediagnost   (Germany)

^b Gesellschaft zur Förderung von Medizin   (Germany)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Autoantibody; ELISA; Multiple sclerosis; Myelin antigen; Neuronal antigen

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SERUM; VALIDATION PROCESS;

BOVINAE;

EID: 73349140846     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.313     Document Type: Article

References (25)

1. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005;23:683-747.
2. Confavreux C, Vukusic S. Natural history of multiple sclerosis: implications for counselling and therapy. Curr Opin Neurol 2002;15:257-266
3. Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372:1502-1517
4. Owens GP, Bennett JL, Lassmann H, O'Connor KC, Ritchie AM, Shearer A, et al. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann Neurol 2009;65:639-649
5. Luxton RW, Zeman A, Holzel H, Harvey P, Wilson J, Kocen R, et al. Affinity of antigen-specific IgG distinguishesmultiple sclerosis from encephalitis. J Neurol Sci 1995;132:11-19
6. Aboul-Enein F, Bauer J, Klein M, Schubart A, Flügel A, Ritter T, et al. Selective and antigen-dependent effect of myelin degeneration on central nervous system inflammation. J Neuropathol Exp Neurol 2004;63:1284-1296
7. Link H. Bedside to bench: betting on B cells in multiple sclerosis. Nat Med 2008;14:615-616
8. Franciotta D, Salvetti M, Lolli F, Serafini B, Aloisi F. B cells and multiple sclerosis. Lancet Neurol 2008;7:852-858
9. Obermeier B, Mentele R, Malotka J, Kellermann J, Kumpfel T, Wekerle H, et al. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med 2008;14: 688-693
10. Lily O, Palace J, Vincent A. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study. Brain 2004;127:269-279
11. Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F, et al. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 1999;122(Pt 11):2047-2056
12. Sellebjerg F, Christiansen M, Garred P. MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis. Mult Scler 1998;4:127-131
13. Khalil M, Reindl M, Lutterotti A, Kuenz B, Ehling R, Gneiss C, et al. Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: influence of relapses and immunomodulatory treatments. J Neuroimmunol 2006; 174:147-156
14. Lefranc D, Almeras L, Dubucquoi S, De Seze J, Vermersch P, Prin L. Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis as a new diagnostic tool. J Immunol 2004;172:669-678
15. Mathey E, Breithaupt C, Schubart AS, Linington C. Commentary: sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire. Eur J Immunol 2004;34:2065-2071
16. Mantegazza R, Cristaldini P, Bernasconi P, Baggi F, Pedotti R, Piccini I, et al. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association. Int Immunol 2004;16:559-565
17. Wang H, Munger KL, Reindl M, O'Reilly EJ, Levin LI, Berger T, et al. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology 2008;71:1142-1146
18. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127
19. Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, et al. B-cell depletion with rituximab in relapsingremitting multiple sclerosis. N Engl J Med 2008;358: 676-688
20. Bech E, Jakobsen J, Orntoft TF. ELISA-type titertray assay of IgM anti-GM1 autoantibodies. Clin Chem 1994; 40:1331-1334
21. Bühlmann AG. Product Information anti-MAG IgM. http://www. buhlmannlabs.ch/files/documents/core/Neuroimmunologie/german/EK-MAG-TF020Dweb. pdf. Accessed 2008.
22. Consortium U. The Universal Protein Resource (UniProt). Nucleic Acids Res 2008;36:D190-5.
23. Jain E, Bairoch A, Duvaud S, Phan I, Redaschi N, Suzek BE, et al. Infrastructure for the life sciences: design and implementation of the UniProt website. BMC Bioinformatics 2009;10:136.
24. Beniac DR, Luckevich MD, Czarnota GJ, Tompkins TA, Ridsdale RA, Ottensmeyer FP, et al. Three-dimensional structure of myelin basic protein. I. Reconstruction via angular reconstitution of randomly oriented single particles. J Biol Chem 1997;272:4261-4268
25. Rispoli P, Carzino R, Svaldo-Lanero T, Relini A, Cavalleri O, Fasano A, et al. A thermodynamic and structural study of myelin basic protein in lipid membrane models. Biophys J 2007;93:1999-2010.